Valente Manuela 4
4 · SOPHiA GENETICS SA · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CPO Manuela Valente Sells 380 Shares
What Happened
Manuela Valente, Chief People Officer of SOPHiA GENETICS SA (SOPH), sold 380 shares on 2026-05-19 in open-market transactions. The filing reports a weighted-average price of $4.60 per share (total proceeds ~$1,747); individual trades ranged $4.54–$4.65. According to the filing, the sales were to satisfy tax withholding obligations tied to the vesting of restricted stock units and were executed under a pre-established Rule 10b5-1(c) plan (non-discretionary).
Key Details
- Transaction date: 2026-05-19; Form 4 filed 2026-05-20 (timely filing).
- Reported sale: 380 shares; weighted-average price $4.60; price range $4.54–$4.65.
- Proceeds: approximately $1,747.
- Purpose/footnote F1: Shares sold to cover tax withholding from RSU vesting on 2026-05-18; sales effected under a pre-established 10b5-1(c) plan (non-discretionary).
- Pricing detail/footnote F2: Price is a weighted average; Reporting Person can provide per-trade breakdown on request.
- Shares owned after transaction: not stated in the provided filing.
Context
These sales were tax-withholding related and executed under a Rule 10b5-1 plan, which is commonly used for routine, pre-planned dispositions and is not an ad hoc insider sell signal. The transaction size ($~1.7K) is small relative to typical market moves and does not, by itself, indicate management sentiment about the company’s outlook.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-05-19$4.60/sh−380$1,747→ 214,691 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.65, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.